Compare TWST & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | PRVA |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.7B |
| IPO Year | 2018 | 2021 |
| Metric | TWST | PRVA |
|---|---|---|
| Price | $57.51 | $24.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $46.88 | $31.17 |
| AVG Volume (30 Days) | ★ 1.3M | 750.6K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | 63.64 |
| EPS | N/A | ★ 0.18 |
| Revenue | $376,572,000.00 | ★ $2,122,842,000.00 |
| Revenue This Year | $18.91 | $18.19 |
| Revenue Next Year | $15.07 | $10.72 |
| P/E Ratio | ★ N/A | $134.78 |
| Revenue Growth | 20.32 | ★ 22.26 |
| 52 Week Low | $23.30 | $18.78 |
| 52 Week High | $66.06 | $26.51 |
| Indicator | TWST | PRVA |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 59.78 |
| Support Level | $41.85 | $22.63 |
| Resistance Level | $57.88 | $25.23 |
| Average True Range (ATR) | 3.41 | 0.77 |
| MACD | -0.62 | 0.03 |
| Stochastic Oscillator | 14.35 | 65.62 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.